Daliresp and Breastfeeding
According to the manufacturer of Daliresp (roflumilast), breastfeeding women should not take this medication. Although this drug does pass through breast milk in rats, it is not known if it passes through human breast milk or if it would cause harm to a breastfed infant. If you are nursing, talk to your healthcare provider about the potential risks of Daliresp.
Interested in a Discount on Daliresp?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Enter Your Email Address
Thank you!Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
Daliresp™ (roflumilast) is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). At this time, it is unknown if Daliresp passes through human breast milk. The manufacturer of the medication recommends that women should not take this medication while nursing. Therefore, if you are breastfeeding, talk with your healthcare provider before taking Daliresp.
Although studies have shown that Daliresp passes through breast milk in rats, no research has been done to see if it passes through breast milk in humans. While this lack of information is certainly frustrating, it is important to understand that studies of medications are rarely done in breastfeeding women, as this would usually expose an infant, who may not directly benefit from the medication, to possible risks.
You should discuss breastfeeding and Daliresp use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.